Published in J Cardiovasc Electrophysiol on January 01, 2005
Elevated pulmonary artery systolic pressures are associated with a lower risk of atrial fibrillation following lung transplantation. J Electrocardiol (2012) 1.43
Ivabradine: potential clinical applications in critically ill patients. Clin Res Cardiol (2012) 0.92
A mathematical model of the unidirectional block caused by the pulmonary veins for anatomically induced atrial reentry. J Biol Phys (2014) 0.75
Probing for mechanisms of atrial fibrillation: pulmonary vein ostia. J Cardiovasc Electrophysiol (2005) 0.75
Characteristics of pulmonary vein enlargement in non-valvular atrial fibrillation patients with stroke. Yonsei Med J (2014) 0.75
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation (2010) 6.71
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol (2008) 4.63
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J (2010) 4.13
A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol (2012) 3.57
Dexmedetomidine sedation leading to refractory cardiogenic shock. Anesth Analg (2008) 3.48
Atrial fibrillation and obesity--results of a meta-analysis. Am Heart J (2007) 2.86
Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol (2011) 2.84
Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. Heart Rhythm (2009) 2.82
Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study. J Am Coll Cardiol (2007) 2.79
Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA (2005) 2.56
Echocardiography for cardiac resynchronization therapy: recommendations for performance and reporting--a report from the American Society of Echocardiography Dyssynchrony Writing Group endorsed by the Heart Rhythm Society. J Am Soc Echocardiogr (2008) 2.42
Acute termination of human atrial fibrillation by identification and catheter ablation of localized rotors and sources: first multicenter experience of focal impulse and rotor modulation (FIRM) ablation. J Cardiovasc Electrophysiol (2012) 2.40
Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation (2002) 2.16
Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation (2011) 2.08
Catheter cryoablation of supraventricular tachycardia: results of the multicenter prospective "frosty" trial. Heart Rhythm (2004) 1.86
Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm (2005) 1.83
Prevalence, predictors, and prognosis of atrial fibrillation early after pulmonary vein isolation: findings from 3 months of continuous automatic ECG loop recordings. J Cardiovasc Electrophysiol (2009) 1.82
Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation (2006) 1.81
Influence of left ventricular lead location on outcomes in the COMPANION study. J Cardiovasc Electrophysiol (2009) 1.72
Robotically assisted left ventricular epicardial lead implantation for biventricular pacing. J Am Coll Cardiol (2003) 1.64
Comparative safety of periablation anticoagulation strategies for atrial fibrillation: data from a large multicenter study. Pacing Clin Electrophysiol (2014) 1.60
Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison. Heart Rhythm (2013) 1.57
Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention. J Cardiovasc Electrophysiol (2005) 1.53
Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J Cardiovasc Electrophysiol (2014) 1.53
Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. Heart Rhythm (2010) 1.47
Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: an analysis from the COMPANION Trial. Heart Rhythm (2011) 1.47
Implantable cardioverter-defibrillator therapy and risk of congestive heart failure or death in MADIT II patients with atrial fibrillation. Heart Rhythm (2006) 1.43
Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol (2008) 1.35
Tracheobronchopathia osteochondroplastica: report of three cases. J Comput Assist Tomogr (2002) 1.33
The World Trade Center attack: increased frequency of defibrillator shocks for ventricular arrhythmias in patients living remotely from New York City. J Am Coll Cardiol (2004) 1.28
ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Europace (2012) 1.18
Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. J Am Coll Cardiol (2006) 1.15
Programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock: results from the PROVIDE study. J Cardiovasc Electrophysiol (2013) 1.00
Time-dependent benefit of preventive cardiac resynchronization therapy after myocardial infarction. Eur Heart J (2010) 1.00
Postoperative atrial fibrillation: a billion-dollar problem. J Am Coll Cardiol (2004) 0.96
The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. J Am Coll Cardiol (2009) 0.93
Aortic valve calcification as an incidental finding at CT of the elderly: severity and location as predictors of aortic stenosis. AJR Am J Roentgenol (2006) 0.93
Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis. Am J Cardiol (2008) 0.92
Termination of persistent atrial fibrillation resistant to cardioversion by a single radiofrequency application. Pacing Clin Electrophysiol (2003) 0.90
Long-term ECG monitoring using an implantable loop recorder for the detection of atrial fibrillation after cavotricuspid isthmus ablation in patients with atrial flutter. Heart Rhythm (2013) 0.88
MR imaging of arrhythmogenic right ventricular dysplasia. Magn Reson Imaging Clin N Am (2003) 0.88
Resumption of sinus rhythm in patients with heart failure and permanent atrial fibrillation undergoing cardiac resynchronization therapy: a longitudinal observational study. Eur Heart J (2010) 0.87
Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation. J Am Coll Cardiol (2011) 0.85
CT pulmonary angiography: increasingly diagnosing less severe pulmonary emboli. PLoS One (2013) 0.85
Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm (2010) 0.84
Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation. J Am Coll Cardiol (2006) 0.83
Does atrial fibrillation burden measured by continuous monitoring during the blanking period predict the response to ablation at 12-month follow-up? Heart Rhythm (2012) 0.83
Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol (2012) 0.83
Progression of atrial fibrillation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation: a randomized comparison of drug therapy versus reablation. Circ Arrhythm Electrophysiol (2013) 0.82
Catheter versus surgical ablation of atrial fibrillation after a failed initial pulmonary vein isolation procedure: a randomized controlled trial. J Cardiovasc Electrophysiol (2013) 0.81
What program directors think: results of the 2011 annual survey of the Association of Program Directors in Radiology. Acad Radiol (2012) 0.81
Acute conversion of persistent atrial fibrillation during dofetilide initiation. Pacing Clin Electrophysiol (2007) 0.81
Correlation of QT interval correction methods during atrial fibrillation and sinus rhythm. Am J Cardiol (2013) 0.80
The SELF pathway for the management of syncope. Crit Pathw Cardiol (2006) 0.79
Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: results of a randomized pilot study. J Am Coll Cardiol (2014) 0.79
The rationale for nontransvenous leads and cardiac resynchronization devices. Pacing Clin Electrophysiol (2003) 0.79
Midterm Follow-up of Robotic Biventricular Pacing Demonstrates Excellent Lead Stability and Improved Response Rates. Innovations (Phila) (2006) 0.78
Long-term outcome of leads and patients following robotic epicardial left ventricular lead placement for cardiac resynchronization therapy. Pacing Clin Electrophysiol (2010) 0.78
Randomized study of early intravenous esmolol versus oral beta-blockers in preventing post-CABG atrial fibrillation in high risk patients identified by signal-averaged ECG: results of a pilot study. Ann Noninvasive Electrocardiol (2002) 0.78
Pulmonary vein isolation alone in patients with persistent atrial fibrillation: an ablation strategy facilitated by antiarrhythmic drug induced reverse remodeling. J Cardiovasc Electrophysiol (2010) 0.78
Recurrence rate of atrial flutter after initial presentation in patients on drug treatment. Am J Cardiol (2003) 0.78
ACR Appropriateness Criteria on acute respiratory illness. J Am Coll Radiol (2009) 0.78
Role of electrophysiologic studies, signal-averaged electrocardiography, heart rate variability, T-wave alternans, and loop recorders for risk stratification of ventricular arrhythmias. Am J Geriatr Cardiol (2005) 0.77
Intravenous versus oral beta-blockers for prevention of post-CABG atrial fibrillation in high-risk patients identified by signal-averaged ECG: lessons of a pilot study. Card Electrophysiol Rev (2003) 0.77
Patterns of atrial fibrillation after coronary artery bypass surgery. Ann Noninvasive Electrocardiol (2006) 0.77
ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Ann Noninvasive Electrocardiol (2012) 0.77
Acute and chronic sequelae of ventricular dyssynchrony. Prog Cardiovasc Dis (2006) 0.76
Novel pathway for sudden cardiac death prevention. Crit Pathw Cardiol (2009) 0.76
When premature is not premature--the ASCOT study. Eur Heart J (2005) 0.76
Antiarrhythmic induced electrical storm in Brugada syndrome: a case report. Ann Noninvasive Electrocardiol (2007) 0.76
Renal denervation for treatment of cardiac arrhythmias: state of the art and future directions. J Cardiovasc Electrophysiol (2014) 0.76
Ablation vs medical therapy in the setting of symptomatic atrial fibrillation and left ventricular dysfunction. Congest Heart Fail (2010) 0.76
Inotropic contractile reserve and response to cardiac resynchronization therapy in patients with markedly remodeled left ventricle. J Am Soc Echocardiogr (2010) 0.76
Managing atrial fibrillation in the CRT patient: controversy or consensus? Heart Rhythm (2012) 0.76
MR imaging of congenital heart disease. Magn Reson Imaging Clin N Am (2003) 0.75
Intracranial emboli associated with catheter ablation of atrial fibrillation: has the silence finally been broken? J Am Coll Cardiol (2011) 0.75
Reply: first-in-humans randomized clinical trial of renal denervation for atrial arrhythmia raises concern. J Am Coll Cardiol (2013) 0.75
Magnetocardiography throws its hat in the ring. J Cardiovasc Electrophysiol (2006) 0.75
Computed tomography imaging of the coronary sinus: a valuable preoperative screen for resynchronization therapy? Cardiol J (2011) 0.75
Dilemma: how to make use of a CARISMA-tic profile? Europace (2011) 0.75
The last shot for "one shot" pulmonary vein isolation with radiofrequency energy? J Cardiovasc Electrophysiol (2014) 0.75
Translation of the RACE pathway for management of atrial fibrillation and atrial flutter into admission forms. Crit Pathw Cardiol (2006) 0.75
Cardiac resynchronization therapy in the setting of permanent atrial fibrillation and heart failure. Curr Opin Cardiol (2008) 0.75
Cardiac memory, a surface electrocardiographic clue in the differential diagnosis of ongoing narrow complex tachycardia. Am J Cardiol (2002) 0.75
Cardioversion in patients with left ventricular thrombus is not associated with increased thromboembolic risk. J Am Soc Echocardiogr (2006) 0.75
The rate control, anticoagulation therapy, and electrophysiology/antiarrhythmic medication pathway for the management of atrial fibrillation and atrial flutter. Crit Pathw Cardiol (2005) 0.75
Anatomic substrate, procedural results, and clinical outcome of ultrasound-guided left atrial-pulmonary vein disconnection for treatment of atrial fibrillation. Am J Cardiol (2005) 0.75
Treatment of atrial fibrillation in hypertrophic cardiomyopathy. Anadolu Kardiyol Derg (2006) 0.75
Cardioversion of atrial fibrillation. Prog Cardiovasc Dis (2005) 0.75
Stem cell therapy for electrophysiological disorders. Curr Cardiol Rep (2013) 0.75
Continuous monitoring of atrial fibrillation in heart failure. Heart Fail Clin (2013) 0.75
Temporary Spinal Cord Stimulation to Prevent Postcardiac Surgery Atrial Fibrillation: 30-Day Safety and Efficacy Outcomes. J Am Coll Cardiol (2022) 0.75
The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT. J Cardiovasc Electrophysiol (2014) 0.75
Images in cardiology: acute anterior wall myocardial infarction in a young male with hypertrophic cardiomyopathy and myocardial bridging. Clin Cardiol (2005) 0.75
The long and winding road. Cardiol J (2013) 0.75
Follow-up of robotically assisted left ventricular epicardial leads for cardiac resynchronization therapy. J Am Coll Cardiol (2005) 0.75